Q1 Earnings Estimate for Curaleaf Issued By Atb Cap Markets

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Equities research analysts at Atb Cap Markets issued their Q1 2025 earnings per share estimates for Curaleaf in a report released on Tuesday, March 4th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings of ($0.05) per share for the quarter. The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Atb Cap Markets also issued estimates for Curaleaf’s Q2 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.19) EPS.

Separately, Roth Capital raised Curaleaf to a “strong-buy” rating in a report on Sunday, November 10th.

Curaleaf Stock Down 2.9 %

Shares of CURLF opened at $1.01 on Friday. The company has a market capitalization of $667.23 million, a P/E ratio of -3.48 and a beta of 0.57. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51. Curaleaf has a one year low of $0.88 and a one year high of $6.40. The business’s 50 day simple moving average is $1.42 and its 200-day simple moving average is $2.16.

Curaleaf (OTCMKTS:CURLF) last announced its earnings results on Monday, March 3rd. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.09. The business had revenue of $331.05 million for the quarter, compared to the consensus estimate of $331.87 million. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.